Anika Therapeutics

Anika Therapeutics

World Rank (Jan-05-2024)
15,164
Market Cap (Jan-05-2024)
0.331 Billion USD
World Rank (Jul-30-2023)
14,877
Market Cap (Jul-30-2023)
0.355 Billion USD
World Rank (Jan-07-2022)
13,435
Market Cap (Jan-07-2022)
0.496 Billion USD
World Rank (Jan-01-2021)
9,945
Market Cap (Jan-01-2021)
0.643 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
ANIK
Market Cap (Mar-08-2026)
0.19
Employee Count
297
Employee Count as of Date
As on 2021
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
147 Million USD
Annual Net Income in USD
4 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
347 Million USD
Total Liabilities in USD
60 Million USD
Total Equity in USD
287 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Medical Equipment / Instruments
HealthCare Products
Biotechnology
Company Website
ANIKA THERAPEUTICS INC
Yahoo
Yahoo @ Nasdaq
Company Profile

Anika offers a broad spectrum of therapeutic treatments ranging from osteoarthritis pain management to joint preservation and restoration. Its proprietary technology is based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body vital for proper joint health and tissue function.

Stock Exchange
Nasdaq
Company SubCategory
Top Healthcare Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Medical/Dental Instruments

Share